Faron logo

Faron

A CLEVER Approach to Fight Cancer.

61 employees · est. 2007 · Turku, Finland

VS
Nectin Therapeutics logo

Nectin Therapeutics

Unlocking the power of the immune system - next-generation immunotherapy

12 employees · est. 2017 · Jerusalem, Israel

Faron is the older company (2007 vs 2017); Faron is the larger of the two.

Side-by-Side Comparison

Faron Nectin Therapeutics
Founded
2007 older 2017
Headquarters
Turku, Finland Jerusalem, Israel
Employees
61 larger 12
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Life Sciences
Funding Stage
Post Ipo Debt Series Unknown
Total Funding
$61.34M $46.40M
Funding Rounds
9 6
Services
Development of innovative cancer therapies, Conducting clinical trials, Research in immunotherapy and myeloid cell-targeting, Drug candidate investigation and development Not tracked yet
Target Customers
Cancer patients, Healthcare professionals, Clinical researchers, Investors in biopharmaceuticals Not tracked yet
Taxonomy
Clinical Stage Biopharmaceutical, Bexmarilimab, Precision Immunotherapy, Macrophage Checkpoint Immunotherapy, Hematological Malignancies, Anti-Clever-1 Antibody, Immune Activation, Acute Organ Traumas, Vascular Damage, Drug Discovery, Drug Development, Cancer Immunotherapy, ARDS, Acute Respiratory Distress Syndrome, Novel Treatments For Unmet Medical Needs Biotech, Immunotherapy, Cancer Therapy, Immune System, Therapeutic Agents, Antibodies, Resistance Mechanisms, CAR-T, CAR-NK, Targeted Therapy, Oncology, Novel Agents, Immune Cell, Tumor Targeting, Drug Development
Website
faron.com nectintx.com
Faron logo

About Faron

Faron, a clinical stage biopharmaceutical company with the slogan "A CLEVER Approach to Fight Cancer," is focused on developing novel immunotherapies to address unmet medical needs. Headquartered in Turku, Finland, and Boston, Massachusetts, its flagship program is bexmarilimab, an investigational p...

Nectin Therapeutics logo

About Nectin Therapeutics

Nectin Therapeutics is a biotech company founded in 2017 with its headquarters in Israel. The company's focus is on unlocking the power of the immune system and developing next-generation immunotherapy agents. Nectin Therapeutics aims to address the limitations of existing immunotherapy by targeting...

We will tell you when either one moves

BounceWatch watches Faron and Nectin Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Faron and Nectin Therapeutics — by email.

Frequently Asked Questions

Faron — A CLEVER Approach to Fight Cancer.. Nectin Therapeutics — Unlocking the power of the immune system - next-generation immunotherapy . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Faron has raised $61.34M while Nectin Therapeutics has raised $46.40M.
Faron and Nectin Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Faron with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Faron on 15 Jun 2026, and Nectin Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes